Gainers
- CytoMed Therapeutics GDTC stock moved upwards by 153.9% to $8.86 during Tuesday's pre-market session. The market value of their outstanding shares is at $102.1 million.
- Better Therapeutics BTTX stock rose 35.55% to $1.22. The market value of their outstanding shares is at $38.7 million.
- Cingulate CING stock rose 28.64% to $1.19. The market value of their outstanding shares is at $13.9 million.
- TC BioPharm (Holdings) TCBP shares moved upwards by 25.3% to $0.56. The company's market cap stands at $2.6 million.
- Adial Pharmaceuticals ADIL stock rose 18.63% to $0.24. The company's market cap stands at $7.1 million.
- Acumen Pharmaceuticals ABOS stock rose 13.88% to $5.65. The market value of their outstanding shares is at $231.7 million.
Losers
- Viridian Therapeutics VRDN stock decreased by 17.1% to $20.33 during Tuesday's pre-market session. The company's market cap stands at $876.8 million.
- BioRestorative Therapies BRTX shares declined by 14.33% to $3.05. The company's market cap stands at $11.8 million.
- Iovance Biotherapeutics IOVA shares decreased by 12.06% to $7.73. The company's market cap stands at $1.7 billion.
- Enzo Biochem ENZ stock fell 9.9% to $1.64. The market value of their outstanding shares is at $81.5 million.
- Enochian BioSciences ENOB shares decreased by 8.69% to $0.47. The market value of their outstanding shares is at $30.1 million.
- Histogen HSTO shares fell 7.77% to $0.81. The market value of their outstanding shares is at $3.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ADILAdial Pharmaceuticals Inc
$1.051.94%
BRTXBioRestorative Therapies Inc
$1.530.66%
BTTXBetter Therapeutics Inc
$0.008007900.0%
CINGCingulate Inc
$4.902.93%
ENZEnzo Biochem Inc
$0.75862.38%
GDTCCytoMed Therapeutics Ltd
$2.35-2.08%
HSTOHistogen Inc COM NEW
$0.2150-67.3%
IOVAIovance Biotherapeutics Inc
$7.43-0.40%
TCBPTC BioPharm (Holdings) PLC
$0.65002.20%
VRDNViridian Therapeutics Inc
$19.31-1.83%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in